← Back to front page
United States · Exchanges & live quotes · Nasdaq

Zymeworks Authorized To Buy Back Up To $200 Mln Of Shares

Published by Nasdaq · United States 1 h ago

Detailed summary

(RTTNews) - Zymeworks Inc. (ZYME), a biotechnology company, said Monday that its Board has authorized a second share repurchase program of up to $200 million, which is expected to…

Read the full article on Nasdaq Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nasdaq.com)

Also worth reading